Honasa Consumer Ltd, on Tuesday said it will acquire 58 per cent stake in Fluence Pharma, which is a science-backed nutraceuticals company. This marks the beauty and personal care company’s entry in the rapidly growing nutraceuticals space
In a BSE filing, Honasa Consumer said that it will acquire a majority stake of 58 per cent of Fluence Pharma via secondary purchase at about ₹135 crores enterprise value, subject to closing adjustments and completion of conditions precedent. It added that it will acquire the remaining 42 per cent stake in the company through secondary purchase in two tranches over the next 5-7 years from completion of acquisition.
Noting that the nutraceuticals category is at an inflection point in India, driven by rising consumer demand for holistic, “beauty-from-inside” interventions and an active awareness of nutritional gaps. “This strategic expansion targets India’s rapidly growing nutraceuticals market, which is currently valued at over ₹16,000 crore. Through this acquisition, Honasa Consumer will execute its entry into the category by establishing its dedicated subsidiary, Honasa Health Private Ltd,” it added. The new entity will scale a differentiated B2C nutrition portfolio.
In a statement, Varun Alagh, Co-founder and CEO, Honasa Consumer Limited, said, “The beauty and personal care landscape is entering a new era where consumers are increasingly seeking holistic, inside-out solutions that address beauty concerns at their root. While the last decade was shaped by topical actives, we believe the next decade will be defined by the powerful convergence of science-backed skin and hair care, and nutraceuticals. Fluence has built a strong scientific foundation through its patented Cyclical Nutrition Therapy, setting a benchmark for clinically validated efficacy.”
“We are excited to build on this foundation and scale it through Honasa Health, creating a consumer-first nutraceuticals franchise that complements our science-led beauty portfolio. This marks an important step in our vision of building a future-ready House of Brands and a more resilient, diversified growth engine,” he added.
Published on June 24, 2026
Source link
#Honasa #Consumer #acquire #stake #Fluence #Pharma
